Background: Atrial tachycardia (AT) and atrioventricular reentrant tachycardia (AVNRT) are known triggers of atrial fibrillation (AF) and are potential targets for curative ablation. These arrhythmias commonly present before age 35 but may not be recognized until later in life. We sought to determine whether patients with symptoms of atrial fibrillation as young adults referred for treatment of atrial fibrillation had a higher incidence of non-pulmonary vein (PV) triggers. Methods: Data on 292 patients referred for catheter ablation for treatment of AF (January 1999 -September 2003 was retrospectively analyzed to determine the potential differences in age specific triggers. Data were collected during initial patient interview and included duration of AF symptoms. Electrophysiological studies using multipolar catheters during isoproterenol infusion identified triggers initiating AF as originating from a PV or other atrial source. Non-PV triggers were further characterized as AT or AVNRT and were confirmed by failure to re-initiate AF after successful ablation. Bivariate correlation and multivariable logistic regression were performed to evaluate the association between non-PV triggers of AF and younger age. Results: Of the 292 patients in the cohort, 46 experienced symptoms attributable to AF before age 35 (mean 28.4 ± 5.5 years). The mean age of these patients at the time of ablation was 37.9 ± 9.1 years vs. 56.0 ± 8.9 years in the rest of the cohort. There were 28 AT and 10 AVNRT triggers of AF in the cohort. After adjustment for sex, left atrial size, mitral regurgitation, history of hypertension, coronary artery disease, congestive heart failure or sleep apnea, younger age at time of symptom onset remained significantly associated with the presence of non-PV triggers (risk ratio: 2.56 (1.2 -6.2); P=0.03). Younger age was not associated with the presence of AT (P=0.39) but was significantly associated with the presence of AVNRT (P=0.01).
Dogs with rapid ventricular pacing (RVP)-induced congestive heart failure (CHF) have inducible sustained atrial tachycardia (AT) and atrial fibrillation (AF). However, the relationship of AT to AF in experimental CHF is uncertain. We hypothesized that induction of sustained AF is often preceded by AT in this CHF model. Methods Characteristics and patterns of sustained (>10 min) AF and AT initiation were analyzed in dogs with CHF produced by 3 to 5 weeks of RVP at 240 beats per minute. Results Among 43 episodes of sustained atrial arrhythmias in 23 CHF dogs: 1) in 10 (23%) episodes in 8 dogs sustained AF was preceded by a transitional rhythm of AT with spontaneous conversion of AT to AF; 2) in 12 (28%) episodes in 8 dogs sustained AF was present for the entire episode duration; and 3) in 21 episodes (49%) in 14 dogs sustained AT was present for the duration. The mean time to spontaneous conversion of AT to AF was 154 sec (range 10-300sec). During 3 (7%) episodes in 2 dogs, AF alternated with AT during an episode. Episodes of AT that spontaneously converted to AF had shorter cycle lengths than those that persisted as AT (139±14 ms vs. 153±15 ms, p=0.038). The duration of RVP among dogs with only AT induced (n=9), only AF induced (n=5), and with AT to AF (n=8) did not differ significantly (3.9±1.1 vs. 4.2±1.1 vs. 4.1±1.1 weeks). Left atrial end-diastolic volume measured by transesophageal echocardiography among dogs with only AT induced, only AF induced, and with AT to AF was not significantly different (43±12 vs. 44±25 vs. 39±5 cc). Right atrial effective refractory period at 400 ms was longer in dogs in which only AF was induced compared with those in which only AT was induced (164±31 vs. 134±19 ms, p=0.055). Verapamil terminated 6 of 7 sustained AT and 4 of 5 sustained AF episodes (AF only or AT to AF). Conclusions Dogs with RVP induced CHF frequently have both sustained AT and AF induced. A transitional rhythm of AT with spontaneous conversion to sustained AF occurs. Episodes of AT that convert to AF have shorter cycle lengths than those that persist as AT. Verapamil terminates both AT and AF in this CHF model. These observations imply that there is a potential mechanistic link and interaction between AT and AF in CHF. Results: Gender distribution, body-mass index, and neck circumference were similar between groups. The control group was younger (mean age 50 vs. 71 years, p<0.0001). The proportion of patients at high risk for OSA was significantly higher in the AF group compared to hypertensive controls (49% vs. 34%, p=0.006). This was especially true for AF patients with hypertension (n=97, 56%, p=0.0005) and those with hypertension but without diabetes, coronary artery disease, or congestive heart failure (n=53, 51%, p=0.03). In this latter group, the odds of being at high risk for OSA was 2.0 times greater than in the hypertensive controls (95%CI: 1.1 to 3.7).
Conclusion:
The novel finding of this study is that the risk of OSA is strikingly high in patients with AF, even higher than in hypertensive patients. Older age in the AF group strengthens these findings, as OSA prevalence usually decreases after age 60 years. These results have important clinical implications, since OSA contributes to an increased risk for recurrence of AF after cardioversion, and treatment of OSA lowers this risk.
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